YES I agree with that but maybe not if it was a pre-existing Eontec client using Eontec formula and machines (Tesla). I honestly think that LQMT will only see revenue when their formula and or process is used regardless of where the client is based. Remember there is no shared ownership between the two entities, Lugee sees the bigger picture and is interested in LQMT filling a nitch that Eontec couldn’t in order to cover all the bases and eventual applications. Not sure CHINESE Mfg standards would ever be suitable for American medical market, but someone could correct me on that as I have no idea where current medical products are predominantly manufactured.
News 
Market Data 
Discover 
AI
